ClinicalTrials.Veeva

Menu

Efficacy of Hypnotherapy for Agoraphobia (WIKI-A)

U

University Hospital Tuebingen

Status

Completed

Conditions

Agoraphobia

Treatments

Behavioral: Hypnotherapy for Agoraphobia

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of the study is to compare the efficacy of Hypnotherapy for the treatment of Agoraphobia compared to a wait-list control group.

Full description

With the present study, the efficacy of 8-12 sessions of individual Hypnotherapy will be compared to a wait-list control groups. At study entry and at the end of treatment with Hypnotherapy, the Agoraphobia symptoms will be assessed via clinician-rating and self-report. It is expected that Hypnotherapy will be superior to a wait-list control regarding the percentage reduction of the anxiety symptoms after three months of treatment.

Enrollment

36 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Written informed consent
  • Patient fulfills DSM-5 (Diagnostic and Statistical Manual of Mental Disorders) criteria for agoraphobia
  • 18 - 65 years of age
  • Sufficient knowledge of the German language in order to participate in the study
  • Sufficient availability to participate in weekly therapy sessions

Exclusion criteria

  • Acute suicidality (intended action, concrete plans or intermittent pronounced suicidal ideation)
  • Lifetime diagnosis of a bipolar disorder or psychotic disorder
  • Alcohol or substance use disorder without abstinence in the last 12 months
  • Severe cognitive impairments (in cases of suspicion evaluation via Mini Mental State Test (MMST) < 26, will be conducted)
  • Other severe primary mental disorders to be treated: severe Major Depressive Disorder, severe personality disorder of borderline type with self-injury, severe combined personality disorder, actual posttraumatic stress disorder, anorexia nervosa, obsessive compulsive disorder
  • Somatic disorder impeding participation in regular psychotherapy sessions
  • Outpatient psychotherapy during the last twelve months.
  • Medication with anxiolytics or anti-psychotics (antidepressant medication is permitted if stable since more than eight weeks and no planned changes during the duration of therapy)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

36 participants in 2 patient groups

Hypnotherapy for Agoraphobia
Experimental group
Description:
A total of 8-12 individual sessions of hypnotherapy over 12 weeks will be delivered. Hypnotherapy consists of hypnotic activation and reinforcement of the patient's own resources, the use of relevant positive and negative experiences from the biography, and the development of positive solution imagery. The central technique is the work with a symptom regression and the resolution of old and actual experiences. Furthermore, formal trance induction, utilisation techniques, indirect techniques such as the use of metaphors or the representative technique, or work with time progression will be used.
Treatment:
Behavioral: Hypnotherapy for Agoraphobia
Wait-list control group
No Intervention group
Description:
Patients in the wait-list control group will receive 8-12 sessions of individual hypnotherapy after a waiting period for 12 weeks.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems